U.S. Markets closed
  • S&P 500

    3,638.35
    +8.70 (+0.24%)
     
  • Dow 30

    29,910.37
    +37.90 (+0.13%)
     
  • Nasdaq

    12,205.85
    +111.44 (+0.92%)
     
  • Russell 2000

    1,855.27
    +10.25 (+0.56%)
     
  • Crude Oil

    45.53
    -0.18 (-0.39%)
     
  • Gold

    1,788.10
    -23.10 (-1.28%)
     
  • Silver

    22.64
    -0.81 (-3.44%)
     
  • EUR/USD

    1.1970
    +0.0057 (+0.4788%)
     
  • 10-Yr Bond

    0.8420
    -0.0360 (-4.10%)
     
  • Vix

    20.84
    -0.41 (-1.93%)
     
  • GBP/USD

    1.3314
    -0.0042 (-0.3169%)
     
  • USD/JPY

    104.0850
    -0.1650 (-0.1583%)
     
  • BTC-USD

    18,102.08
    +334.03 (+1.88%)
     
  • CMC Crypto 200

    333.27
    -4.23 (-1.25%)
     
  • FTSE 100

    6,367.58
    +4.65 (+0.07%)
     
  • Nikkei 225

    26,644.71
    +107.40 (+0.40%)
     

MERGER ALERT – BSTC, CBLI, and RESI: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

·2 min read

NEW YORK, NY / ACCESSWIRE / October 23, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:

Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies.

BioSpecifics Technologies Corp. (NASDAQ:BSTC)
Merger Announcement: October 19, 2020
Transaction Details: Under the terms of the deal, Endo will commence an all-cash tender offer for all outstanding shares of BioSpecifics common stock at a price of $88.50 per share.

To learn more about the BSTC investigation and your rights, go to:
https://www.zlk.com/mna2/biospecifics-technologies-corp-information-request-form

Cleveland BioLabs, Inc. (NASDAQ:CBLI)
Agreement Announcement: October 20, 2020
Transaction Details: Under the terms of the merger, BioLabs stockholders will control only 39% of the combined company.

To learn more about the CBLI investigation and your rights, go to:
https://www.zlk.com/mna2/cleveland-biolabs-inc-information-request-form

Front Yard Residential Corporation (NYSE:RESI)
Merger Announcement: October 19, 2020
Transaction Details: ). Under the terms of the deal, Front Yard stockholders will receive $13.50 in cash per share.

To learn more about the RESI investigation and your rights, go to:
https://www.zlk.com/mna2/front-yard-residential-corporation-information-request-form

Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
jlevi@levikorsinsky.com
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/612003/MERGER-ALERT-BSTC-CBLI-and-RESI-Levi-Korsinsky-LLP-Reminds-Investors-of-Investigations-Concerning-the-Mergers-of-these-Companies